申请人:Nycomed GmbH
公开号:EP2402330A1
公开(公告)日:2012-01-04
Fixed combination, non-fixed combination or kit of parts comprising 1-(2-4-[3-(3,4-dimethoxyphenyl)-4,4-dimethyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl]piperidin-1-yl}-2-oxoethyl)pyrrolidine-2,5-dione, metformin or a pharmaceutically acceptable salt of metformin, and at least one pharmaceutically acceptable auxiliary.
包含 1-(2-4-[3-(3,4-二甲氧基苯基)-4,4-二甲基-5-氧代-4,5-二氢-1H-吡唑-1-基]哌啶-1-基}-2-氧代乙基)吡咯烷-2,5-二酮、二甲双胍或二甲双胍的药学上可接受的盐,以及至少一种药学上可接受的助剂的固定组合物、非固定组合物或部件试剂盒。